NRC Health Revenues
NRC Health (NRC) reported Revenues of $119.69 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2019-03-08
- NRC Health revenues for the quarter ending 2017-12-31 was $29.90M, a 5.39% increase year-over-year.
- NRC Health revenues for the quarter ending 2017-09-30 was $28.95M, a 7.10% increase year-over-year.
- NRC Health revenues for the quarter ending 2017-06-30 was $28.43M, a 8.89% increase year-over-year.
- NRC Health revenues for the quarter ending 2017-03-31 was $30.28M, a 8.63% increase year-over-year.
- NRC Health revenues for fiscal 2018 was $119.69M, a 1.81% increase from fiscal 2017.
- NRC Health revenues for fiscal 2017 was $117.56M, a 7.47% increase from fiscal 2016.
- NRC Health revenues for fiscal 2016 was $109.38M, a 6.88% increase from fiscal 2015.
- NRC Health revenues for fiscal 2015 was $102.34M, a 3.55% increase from fiscal 2014.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-12-31 | $119.69M 10-K · filed 2019-03-08 | |||
| 2017-12-31 | $29.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $58.85M derived: sum of 2 quarters · filed 2019-03-08 | $87.28M derived: sum of 3 quarters · filed 2019-03-08 | $117.56M 10-K · filed 2019-03-08 |
| 2017-09-30 | $28.95M 10-Q · filed 2017-11-09 | $57.39M derived: sum of 2 quarters · filed 2017-11-09 | $87.66M 10-Q · filed 2017-11-09 | $116.03M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $28.43M 10-Q · filed 2017-08-04 | $58.71M 10-Q · filed 2017-08-04 | $87.08M derived: sum of 3 quarters · filed 2019-03-08 | $114.11M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $30.28M 10-Q · filed 2017-05-05 | $58.64M derived: sum of 2 quarters · filed 2019-03-08 | $85.68M derived: sum of 3 quarters · filed 2019-03-08 | $111.79M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $28.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $55.40M derived: sum of 2 quarters · filed 2019-03-08 | $81.51M derived: sum of 3 quarters · filed 2019-03-08 | $109.38M 10-K · filed 2019-03-08 |
| 2016-09-30 | $27.03M 10-Q · filed 2017-11-09 | $53.15M derived: sum of 2 quarters · filed 2017-11-09 | $81.02M 10-Q · filed 2017-11-09 | $107.38M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $26.11M 10-Q · filed 2017-08-04 | $53.98M 10-Q · filed 2017-08-04 | $80.35M derived: sum of 3 quarters · filed 2018-03-14 | $105.59M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $27.87M 10-Q · filed 2017-05-05 | $54.23M derived: sum of 2 quarters · filed 2018-03-14 | $79.48M derived: sum of 3 quarters · filed 2018-03-14 | $103.94M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $26.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $51.61M derived: sum of 2 quarters · filed 2018-03-14 | $76.07M derived: sum of 3 quarters · filed 2018-03-14 | $102.34M 10-K · filed 2018-03-14 |
| 2015-09-30 | $25.24M 10-Q · filed 2016-11-04 | $49.71M derived: sum of 2 quarters · filed 2016-11-04 | $75.98M 10-Q · filed 2016-11-04 | $101.10M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $24.46M 10-Q · filed 2016-08-05 | $50.73M 10-Q · filed 2016-08-05 | $75.86M derived: sum of 3 quarters · filed 2017-03-03 | $99.54M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $26.27M 10-Q · filed 2016-05-06 | $51.39M derived: sum of 2 quarters · filed 2017-03-03 | $75.08M derived: sum of 3 quarters · filed 2017-03-03 | $99.08M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $25.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $48.81M derived: sum of 2 quarters · filed 2017-03-03 | $72.81M derived: sum of 3 quarters · filed 2017-03-03 | $98.84M 10-K · filed 2017-03-03 |
| 2014-09-30 | $23.68M 10-Q · filed 2015-11-05 | $47.68M derived: sum of 2 quarters · filed 2015-11-05 | $73.71M 10-Q · filed 2015-11-05 | $96.64M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-06-30 | $24.00M 10-Q · filed 2015-08-06 | $50.03M 10-Q · filed 2015-08-06 | $72.95M derived: sum of 3 quarters · filed 2016-03-04 | $95.36M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-03-31 | $26.03M 10-Q · filed 2015-05-08 | $48.95M derived: sum of 2 quarters · filed 2016-03-04 | $71.36M derived: sum of 3 quarters · filed 2016-03-04 | $93.71M derived: sum of 4 quarters · filed 2016-03-04 |
| 2013-12-31 | $22.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $45.33M derived: sum of 2 quarters · filed 2016-03-04 | $67.68M derived: sum of 3 quarters · filed 2016-03-04 | $92.59M 10-K · filed 2016-03-04 |
| 2013-09-30 | $22.41M 10-Q · filed 2014-11-07 | $44.76M derived: sum of 2 quarters · filed 2014-11-07 | $69.67M 10-Q · filed 2014-11-07 | $91.66M derived: sum of 4 quarters · filed 2015-03-04 |
| 2013-06-30 | $22.35M 10-Q · filed 2014-08-06 | $47.26M 10-Q · filed 2014-08-06 | $69.26M derived: sum of 3 quarters · filed 2015-03-04 | $90.64M derived: sum of 4 quarters · filed 2015-03-04 |
| 2013-03-31 | $24.91M 10-Q · filed 2014-05-08 | $46.90M derived: sum of 2 quarters · filed 2015-03-04 | $68.29M derived: sum of 3 quarters · filed 2015-03-04 | $88.92M derived: sum of 4 quarters · filed 2015-03-04 |
| 2012-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $43.38M derived: sum of 2 quarters · filed 2015-03-04 | $64.01M derived: sum of 3 quarters · filed 2015-03-04 | $86.42M 10-K · filed 2015-03-04 |
| 2012-09-30 | $21.39M 10-Q · filed 2013-11-07 | $42.02M derived: sum of 2 quarters · filed 2013-11-07 | $64.42M 10-Q · filed 2013-11-07 | $83.54M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-06-30 | $20.63M 10-Q · filed 2013-08-08 | $43.04M 10-Q · filed 2013-08-08 | $62.15M derived: sum of 3 quarters · filed 2014-03-04 | $80.70M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-03-31 | $22.41M 10-Q · filed 2013-05-08 | $41.52M derived: sum of 2 quarters · filed 2014-03-04 | $60.07M derived: sum of 3 quarters · filed 2014-03-04 | $78.38M derived: sum of 4 quarters · filed 2014-03-04 |
| 2011-12-31 | $19.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $37.66M derived: sum of 2 quarters · filed 2014-03-04 | $55.98M derived: sum of 3 quarters · filed 2014-03-04 | $75.77M 10-K · filed 2014-03-04 |
| 2011-09-30 | $18.55M 10-Q · filed 2012-11-07 | $36.87M derived: sum of 2 quarters · filed 2012-11-07 | $56.66M 10-Q · filed 2012-11-07 | $72.54M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $18.32M 10-Q · filed 2012-08-10 | $38.11M 10-Q · filed 2012-08-10 | $53.99M derived: sum of 3 quarters · filed 2013-03-01 | $70.00M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $19.79M 10-Q · filed 2012-05-11 | $35.67M derived: sum of 2 quarters · filed 2013-03-01 | $51.68M derived: sum of 3 quarters · filed 2013-03-01 | $65.82M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $15.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $31.89M derived: sum of 2 quarters · filed 2013-03-01 | $46.03M derived: sum of 3 quarters · filed 2013-03-01 | $63.40M 10-K · filed 2013-03-01 |
| 2010-09-30 | $16.01M 10-Q · filed 2011-11-08 | $30.14M derived: sum of 2 quarters · filed 2011-11-08 | $47.52M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $14.14M 10-Q · filed 2011-08-12 | $31.51M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $57.69M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |